Johnathan M. Lancaster

9.2k citations

98 papers · 5.4k indexed · 1 hit paper · h-index 34

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation

Papers in

Reproductive Medicine 36
- Ovarian cancer diagnosis and treatment 34
Cancer Research 29
- Cancer Genomics and Diagnostics 11
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 7

Co-authors: Andrew Berchuck Jeffrey R. Marks Holly K. Dressman Joseph R. Nevins Mike West Anil Potti Andrea Bild M. Joshi
Journals: Gynecologic Oncology (18 papers)International Journal of Gynecological Cancer (9 papers)American Journal of Obstetrics and Gynecology (7 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (4 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Johnathan M. Lancaster

97 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Oncogenic pathway signatures in human cancers as a guide to targeted therapies 2005 · 1.5k citations

Peers

Countries citing papers authored by Johnathan M. Lancaster

Since Specialization

Citations

This map shows the geographic impact of Johnathan M. Lancaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnathan M. Lancaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnathan M. Lancaster more than expected).

Fields of papers citing papers by Johnathan M. Lancaster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnathan M. Lancaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnathan M. Lancaster. The network helps show where Johnathan M. Lancaster may publish in the future.

Co-authors

The 25 scholars most cited alongside Johnathan M. Lancaster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johnathan M. Lancaster Line = papers co-authored together Johnathan M. Lancaster links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders Clinical Infectious Diseases ·David Stein, Ernesto Oviedo‐Orta, Wendy Kampman, Jennifer McGinniss, Suriyani Wan Mahmud Wan Fatimah, V Vitale, 真穂安田, Johnathan M. Lancaster, Ned Braunstein, George D. Yancopoulos, David M. Weinreich	2021	7
2	Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated ( ATM ) Gene are Associated with High and Moderate Risks for Multiple Cancers Cancer Prevention Research ·Michael J. Hall, Ryan Bernhisel, Elisha Hughes, Camila Silva de Figueiredo, Eric T. Rosenthal, Nanda A. Singh, Johnathan M. Lancaster, Allison W. Kurian	2021	102
3	Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes PLoS ONE ·田中好美, Douglas C. Marchion, Susan McCarthy, Ardeshir Hakam, Alexis S. Lopez, Robert M. Wenham, Sachin M. Apte, Dung‐Tsa Chen, Anthony M. Magliocco, Johnathan M. Lancaster, Brett M. Reid, Jennifer B. Permuth	2021	3
4	Oncology healthcare providers’ knowledge, attitudes, and practice behaviors regarding LGBT health Patient Education and Counseling ·Karin C. Lodrop Carlsen, Julian Sanchez, Johnathan M. Lancaster, Lauren E. Wilson, Gwendolyn P. Quinn, Matthew B. Schabath	2016	122
5	Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data Cancer Research ·Jesús González Bosquet, Douglas C. Marchion, Samer Talat Abu Lubdeh, Johnathan M. Lancaster, Stephen J. Chanock	2014	25
6	Metabolic Vulnerabilities in Endometrial Cancer Cancer Research ·Frances L. Byrne, Ivan K. H. Poon, Susan C. Modesitt, Jose L. Tomsig, Jenny D.Y. Chow, Marin E. Healy, William D. Baker, Kristen A. Atkins, Johnathan M. Lancaster, Douglas C. Marchion, Kelle H. Moley, Kodi S. Ravichandran, Jill K. Slack‐Davis, Kyle L. Hoehn	2014	91
7	Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions Gynecologic Oncology ·Johnathan M. Lancaster, C. Bethan Powell, Lee-may Chen, Debra L. Richardson	2014	193
8	Evidence of a Chemopreventive Effect of Progestin Unrelated to Ovulation on Reproductive Tract Cancers in the Egg-laying Hen Cancer Prevention Research ·Gustavo C. Rodriguez, H. John Barnes, Kenneth E. Anderson, Regina S. Whitaker, Andrew Berchuck, James N. Petitte, Johnathan M. Lancaster, Robert M. Wenham, Jane M. Turbov, Roger Day, G. Larry Maxwell, Kang-Tai	2013	13
9	A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy Gynecologic Oncology ·Robert M. Wenham, James P. LaPolla, Hui‐Yi Lin, Sachin M. Apte, Johnathan M. Lancaster, Patricia L. Judson, Jesús González Bosquet, A. Wennberg, Laura J. Havrilesky, Angeles Alvarez Secord	2013	22
10	A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer Clinical Cancer Research ·Angeles Alvarez Secord, Deanna Teoh, William T. Barry, Miao Yu, Gloria Broadwater, Laura J. Havrilesky, Paula S. Lee, Andrew Berchuck, Johnathan M. Lancaster, Robert M. Wenham	2012	50
11	In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival British Journal of Cancer ·Elona Biçaku, Yin Xiong, Trojanowski, Hye Sook Chon, Kang Li-xiang, Ning Chen, Ujjawal Tyagi, A. Hakam, Jesús González Bosquet, Robert M. Wenham, Sachin M. Apte, William J. Fulp, Christopher Cubitt, Zahra Taheri Hanjani, Johnathan M. Lancaster	2012	32
12	Fascin Protein Is Critical for Transforming Growth Factor β Protein-induced Invasion and Filopodia Formation in Spindle-shaped Tumor Cells Journal of Biological Chemistry ·Jianwei Sun, Darwin Jorge Gil Espinoza, Yin Xiong, Shuang Lü, Junling Shen, Anna Cheng, Wei‐Chiao Chang, Ming‐Feng Hou, Johnathan M. Lancaster, Minjung Kim, Shengyu Yang	2011	52
13	Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome Clinical Cancer Research ·Andrew Berchuck, Edwin S. Iversen, Jingqin Luo, Jennifer Clarke, Hisani N. Horne, Douglas A. Levine, Jeff Boyd, Miguel A. Alonso, Angeles Alvarez Secord, Marcus Q. Bernardini, Jason C. Barnett, Todd Boren, Susan K. Murphy, Holly K. Dressman, Jeffrey R. Marks, Johnathan M. Lancaster	2009	60
14	Electrothermal bipolar coagulation decreases the rate of red blood cell transfusions for pelvic exenterations Journal of Surgical Oncology ·Nisha Bansal, William S. Roberts, Sachin M. Apte, Johnathan M. Lancaster, Robert M. Wenham	2009	7
15	Biomarkers to Discern Transplantation Tolerance after Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Joseph Pidala, Gregory Bloom, Steven A. Enkemann, Steven A. Eschrich, Johnathan M. Lancaster, Claudio Anasetti	2009	5
16	The accuracy of frozen pathology at time of hysterectomy in patients with complex atypical hyperplasia on preoperative biopsy American Journal of Obstetrics and Gynecology ·Christina Majer, Cassebaum, 正紀梶田, Johnathan M. Lancaster	2007	33
17	Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature ·Andrea Bild, Guang Yao, Jeffrey T. Chang, Quanli Wang, Anil Potti, Dawn A. D. Chasse, M. Joshi, David Harpole, Johnathan M. Lancaster, Andrew Berchuck, John A. Olson, Jeffrey R. Marks, Holly K. Dressman, Mike West, Joseph R. Nevins Hit paper breakdown →	2005	1507
18	Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays American Journal of Obstetrics and Gynecology ·Andrew Berchuck, Edwin S. Iversen, Johnathan M. Lancaster, Holly K. Dressman, Mike West, Joseph R. Nevins, Jeffrey R. Marks	2004	80
19	Gene Expression Patterns That Characterize Advanced Stage Serous Ovarian Cancers Journal of the Society for Gynecologic Investigation ·Johnathan M. Lancaster, Holly K. Dressman, Regina S. Whitaker, Laura J. Havrilesky, Jonathan Gray, Jeffrey R. Marks, Joseph R. Nevins, Andrew Berchuck	2003	96
20	A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not? Gynecologic Oncology ·Michael E. Carney, Johnathan M. Lancaster, Clyde D. Ford, Alexander Tsodikov, Charles L. Wiggins	2002	167

About Johnathan M. Lancaster

Johnathan M. Lancaster is a scholar working on Reproductive Medicine, Cancer Research, Obstetrics and Gynecology, Pathology and Forensic Medicine and Genetics, having authored 98 papers that have together received 5.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (34 papers), BRCA gene mutations in cancer (20 papers), Cancer Genomics and Diagnostics (11 papers), Cancer-related molecular mechanisms research (10 papers), Cancer Mechanisms and Therapy (9 papers), MicroRNA in disease regulation (7 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Genetic factors in colorectal cancer (6 papers). The work is most often cited by research in Reproductive Medicine (1.3k citations), Cancer Research (1.6k citations), Obstetrics and Gynecology (403 citations), Oncology (1.2k citations) and Molecular Biology (2.7k citations). Johnathan M. Lancaster has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Andrew Berchuck, Jeffrey R. Marks, Holly K. Dressman, Joseph R. Nevins, Mike West, Anil Potti, Andrea Bild, M. Joshi, John A. Olson and Guang Yao. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, American Journal of Obstetrics and Gynecology, Journal of Clinical Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact